2257. Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.
Kim JW1, Lee KH2,3, Kim JW1, Suh KJ1, Nam AR3, Bang JH3, Bang YJ2,3, Oh DY4,5.